Protective efficacy of anti-neuraminidase monoclonal antibodies against H7N9 influenza virus infection

The H7N9 influenza virus has been circulating in China for more than six years. The neuraminidase (NA) has gained great concern for the development of antiviral drugs, therapeutic antibodies, and new vaccines. In this study, we screened seven mouse monoclonal antibodies (mAbs) and compared their pro...

Descripción completa

Detalles Bibliográficos
Autores principales: Xiong, Fei-Fei, Liu, Xue-Ying, Gao, Fei-Xia, Luo, Jian, Duan, Peng, Tan, Wen-Song, Chen, Ze
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6968527/
https://www.ncbi.nlm.nih.gov/pubmed/31894728
http://dx.doi.org/10.1080/22221751.2019.1708214

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6968527/
https://www.ncbi.nlm.nih.gov/pubmed/31894728
http://dx.doi.org/10.1080/22221751.2019.1708214

Ejemplares similares